Nutriband IncNTRB
Price$7.36Intrinsic value$3.9646% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $1.6M-24.4% YoYTTM through 31 Jul 2026
Net Income -$7MTTM through 31 Jul 2026
Free Cash Flow -$3.7MTTM through 31 Jul 2026

Margins

Current
Gross Margin27.8%
EBITDA Margin-426.5%
Operating Margin-408.4%
Net Margin-430.4%

Returns

-123.2%ROE
-109.0%ROA

Balance Sheet Health

Debt / Equity0.02x
Current Ratio6.36x
Net Debt-$4.4Mnet cash position
Cash & Equivalents$3.4M

Quality Metrics

Altman Z-Score37.38
Piotroski F-Score3 / 9
FCF Margin-226.0%
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25'26
FY2026: $2M
Diluted EPS-$0.49TTM
'21'22'23'24'25'26
FY2026: $-0.71

Dividend

No dividend

Capital Allocation

R&D Spend$1.2M
Capex Intensity1.4%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.